nylidrin has been researched along with Arteriosclerosis in 1 studies
Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| TREPTOW, KR | 1 |
| AFFLECK, DC | 1 |
| ROEHL, CA | 1 |
| SOELLING, WM | 1 |
1 other study available for nylidrin and Arteriosclerosis
| Article | Year |
|---|---|
NYLIDRIN HYDROCHLORIDE IN SENILE ARTERIOSCLEROSIS.
Topics: Arteriosclerosis; Geriatrics; Humans; Intracranial Arteriosclerosis; Nylidrin; Placebos; Psychologic | 1963 |